In a recent study posted to the medRxiv* preprint server, researchers evaluated the impact of the coronavirus disease 2019 (COVID-19) pandemic on the rates of pancreatic enzyme replacement therapy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback